Treatment guidelines for HIV-associated wasting.

Area of Science:

• Immunology
• Nutrition Science
• Endocrinology

Background:

• Acquired immunodeficiency syndrome (AIDS) patients frequently experience weight loss due to decreased body cell mass (BCM).
• Causes of HIV-associated wasting include anorexia, malabsorption, and metabolic changes impacting nutrient utilization.
• Gastrointestinal issues, opportunistic infections, and direct HIV effects contribute to malabsorption and diarrhea.

Purpose of the Study:

• To review the causes and nutritional assessment of HIV-associated wasting.
• To discuss various treatment strategies for weight loss in AIDS patients.
• To evaluate the efficacy of different interventions, including growth hormone therapy.

Main Methods:

• Literature review of studies on HIV-associated wasting.
• Analysis of nutritional assessment components for AIDS patients.
• Evaluation of pharmacological and nutritional interventions.

Main Results:

• Nutritional counseling and addressing opportunistic infections are initial steps, but do not always reverse wasting.
• Total parenteral nutrition, dronabinol, megestrol acetate, and testosterone replacement have varying effects on weight and BCM.
• Mammalian-derived human growth hormone (rhGH[m]) demonstrated sustained weight and BCM gains in clinical trials.

Conclusions:

• HIV-associated wasting requires a comprehensive approach, including nutritional support and targeted therapies.
• While some treatments promote weight gain, rhGH[m] offers sustained gains in BCM for refractory cases.
• Effective management of wasting can improve survival, functioning, and quality of life for AIDS patients.